Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
LaTonya J. Hickson, Larissa G.P. Langhi Prata, Shane A. Bobart et al. · EBioMedicine · 2019
Full textCC BY